Merck Leaders to Speak at Upcoming Global Healthcare Conference
Merck's CEO and head of research will speak at an upcoming conference. Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive vice president and president of Merck Research Laboratories, are scheduled to participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026.
The event will be held online, with a live audio webcast available for investors, analysts, media members, and the general public. The presentation is set to begin at 3:20 p.m. ET.
Merck has been involved in research and development of important medicines and vaccines for over 130 years. As part of its mission to be a premier research-intensive biopharmaceutical company, Merck continues to push the boundaries of innovation in healthcare.